Keywords: CHA2DS2-دارواش; AF; atrial fibrillation; CHA2DS2-VASc; congestive heart failure, hypertension, age â¥75 years, diabetes mellitus, stroke/transient ischemic attack, vascular disease, age 65 to 74 years, sex category; HR; hazard ratio; ICD-9; International Classification
مقالات ISI CHA2DS2-دارواش (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CHA2DS2-دارواش; atrial fibrillation; cardiac surgery; ASCERT; American College of Cardiology Foundation-Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies; AF; atrial fibrillation; CABG; coronary artery bypass gr
Keywords: CHA2DS2-دارواش; Non-valvular atrial fibrillation; Prognosis; Von Willebrand factor; Stroke; Cardiovascular events; Fibrillation atriale non valvulaire; Pronostic; Facteur von Willebrand; Infarctus cérébral; Ãvènements cardiovasculaires; AF; atrial fibrillation; CHADS
Keywords: CHA2DS2-دارواش; ECV; Elective cardioversion; AF; Atrial fibrillation; INR; International normalized ratio; TIA; Transient ischaemic attack; CHA2DS2-VASc; Congestive heart failure, hypertension, age â¥Â 75 years (doubled), diabetes mellitus, prior stroke, transient isc
Keywords: CHA2DS2-دارواش; AF; atrial fibrillation; CHA2DS2-VASc; congestive heart failure, hypertension, age â¥75, diabetes, stroke or transient ischemic attack, vascular disease, age between 65 and 74 and female sex; HAS-BLED; hypertension, abnormal renal and/or liver function,
Keywords: CHA2DS2-دارواش; ACT; activated clotting time; AF; atrial fibrillation; CHA2DS2-VASc; score for prediction of estimated risk of stroke in patients with non-valvular atrial fibrillation; EP; electrophysiologic; HAS-BLED; score that estimates risk of major bleeding for pati
Keywords: CHA2DS2-دارواش; AF; atrial fibrillation; ATT; antithrombotic treatment; CHA2DS2-VASc; congestive heart failure, hypertension, age â¥75 years, diabetes mellitus, stroke or transient ischemic attack, vascular disease, age 65-74 years, female sex category; EORP-AF; EURObse
Keywords: CHA2DS2-دارواش; ACC/AHA; American College of Cardiology/American Heart Association; AF; atrial fibrillation; CHADS2; congestive heart failure, hypertension, age â¥75 years, diabetes mellitus, and prior stroke or transient ischemic attack; CHA2DS2-VASc; congestive heart
Keywords: CHA2DS2-دارواش; Fibrilación auricular; Estratificación del riesgo; Ictus isquémico; Hemorragia intracraneal; Función renal; Biomarcadores; CHA2DS2-VASc; HAS-BLED; Beneficio clÃnico neto; Atrial fibrillation; Risk stratification; Ischemic stroke; Intracranial bleedin
Keywords: CHA2DS2-دارواش; Atrial fibrillation; Liver; Cerebrovascular; Stroke; Antithrombotic; CHA2DS2-VASc;
Keywords: CHA2DS2-دارواش; ATRIA; atrial fibrillation; CHA2DS2-VASc; CHADS2; risk scores; thromboembolism;
Keywords: CHA2DS2-دارواش; stroke; off-pump; hematocrit; transfusion; coronary artery bypass grafting; CHA2DS2-VASc
Keywords: CHA2DS2-دارواش; AF; atrial fibrillation; CHADS2; Congestive heart failure, hypertension, age â¥75 years, diabetes and stroke; CHA2DS2-VASc; Congestive heart failure, hypertension, age â¥75 years, diabetes, stroke, vascular disease, age â¥65 years and sex category; cLA
Keywords: CHA2DS2-دارواش; AF; atrial fibrillation; APT; antiplatelet therapy; BARC; Bleeding Academic Research Consortium; CHA2DS2-VASc; congestive heart failure, hypertension, age ⥠75 years (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 years, sex catego
Keywords: CHA2DS2-دارواش; CHF; congestive heart failure; CHA2DS2-VASc; congestive heart failure, hypertension, age â¥75 years (doubled), diabetes mellitus, stroke (doubled)-vascular disease, age 65 to 74 years, and sex category (female); EKG; electrocardiography; H/H; HEPES-buf
Keywords: CHA2DS2-دارواش; electrocardiography; epidemiology; premature atrial contractions; risk factors; stroke; AE; atrial ectopy; AF; atrial fibrillation; CHA2DS2-VASc; congestive heart failure, hypertension, age 75 years or older, diabetes mellitus, previous stroke or transien
Keywords: CHA2DS2-دارواش; AF; atrial fibrillation; ASA; acetylsalicylic acid; CHADS2; congestive heart failure, hypertension, age â¥Â 75, diabetes, prior stroke/transient ischaemic attack (doubled); CHA2DS2-VASc; congestive heart failure or left ventricular dysfunction, hypertens
Keywords: CHA2DS2-دارواش; AF; atrial fibrillation; CHADS2; congestive heart failure, hypertension, age ⥠75 years, diabetes, stroke (doubled); CHA2DS2-VASc; congestive heart failure, hypertension, age ⥠75 years (doubled), diabetes, stroke or transient ischemic attack (doubled
Keywords: CHA2DS2-دارواش; AF; atrial fibrillation; CAD; coronary artery disease; CHADS2; congestive heart failure, hypertension, age, diabetes, stroke (doubled); CHA2DS2-VASc; congestive heart failure, hypertension, age ⥠75 (doubled), diabetes, stroke (doubled), vascular diseas
Keywords: CHA2DS2-دارواش; Atrial fibrillation; CHADS2; CHA2DS2-VASc; Red cell distribution width; Stroke;
Keywords: CHA2DS2-دارواش; AUC; area under the curve; CHS; Clalit Health Services; CI; confidence interval; HR; hazard ratio; IDI; integrated discrimination improvement; TIA; transient ischemic attack; rIDI; relative integrated discrimination improvement; Atrial fibrillation; CHADS
Keywords: CHA2DS2-دارواش; Fibrilhação auricular; Estratificação do risco tromboembólico; CHA2DS2-VASc; Score de risco hemorrágicoAtrial fibrillation; Thromboembolic risk stratification; CHA2DS2-VASc; Bleeding risk score
Keywords: CHA2DS2-دارواش; AF; atrial fibrillation; CHADS2; congestive heart failure, hypertension, age 75 years or more, diabetes mellitus, previous stroke/transient ischemic attack; CHA2DS2-VASc; congestive heart failure, hypertension, age 75 years or more, diabetes mellitus, pre
Keywords: CHA2DS2-دارواش; AF; atrial fibrillation; ATRIA; Anticoagulation and Risk Factors in Atrial Fibrillation; CHADS2; congestive heart failure, hypertension, age ⥠75 years, diabetes, prior stroke or transient ischemic attack; CHA2DS2-VASc; congestive heart failure, hyperte
Keywords: CHA2DS2-دارواش; Anticoagulant; Antiplatelet; Periprocedural; Atrial fibrillation; CHA2DS2-VASc;
Keywords: CHA2DS2-دارواش; NVAF; Non-valvular atrial fibrillation; TE; Thromboembolism; CHADS2; Congestive heart failure, Hypertension, Age â¥Â 75 years, Diabetes, previous Stroke; CHA2DS2-VASc; Congestive heart failure, Hypertension, Age â¥Â 75 years, Diabetes, previous Stro
Keywords: CHA2DS2-دارواش; atrial fibrillation; ischemic stroke; reclassification; risk stratification; thromboembolism; AF; atrial fibrillation; CHADS2; congestive heart failure, hypertension, age â¥75 years, diabetes, previous stroke; CHA2DS2-VASc; congestive heart failure, hype
The CHA2DS2-VASc score: Not as simple as it seems
Keywords: CHA2DS2-دارواش; CHA2DS2-VASc; Congestive heart failure, hypertension, age, diabetes, prior stroke/TIA, vascular disease, sex category; Atrial fibrillation; Stroke risk stratification; CHA2DS2-VASc score;
The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan
Keywords: CHA2DS2-دارواش; AF; atrial fibrillation; AKI; acute kidney injury; CHA2DS2-VASc; congestive heart failure, hypertension, aged 75â¯years or older, diabetes mellitus, previous stroke/transient ischemic attack, vascular disease, aged 65 to 74â¯years, female; CKD; chronic
A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials
Keywords: CHA2DS2-دارواش; AF; atrial fibrillation; AMADEUS; Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation; CHA2DS2-VASc; Congestive heart failure or left ventricular dysfunction (1), Hypertension (1), Ageâ¥75 (2) or 65-74
Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - “Real World” Experience
Keywords: CHA2DS2-دارواش; ACS; acute coronary syndrome; AF; atrial fibrillation; BARC; bleeding academic research consortium; CAD; coronary artery disease; CHA2DS2-VASc; congestive heart failure, hypertension, ageâ¯â¥â¯75p years (doubled), diabetes mellitus, prior stroke or TIA
Atrial fibrillation: Utility of CHADS2 and CHA2DS2-VASc scores as predictors of readmission, mortality and resource utilization
Keywords: CHA2DS2-دارواش; Atrial fibrillation; CHADS2; CHA2DS2-VASc; Readmission; Mortality;
The CHADS2 and CHA2DS2-VASc scores predict atrial fibrillation in dyslipidemic individuals: Role of incorporating low high-density lipoprotein cholesterol levels
Keywords: CHA2DS2-دارواش; CHADS2; CHA2DS2-VASc; Atrial fibrillation; Cholesterol; High-density lipoprotein; Statin;
Clinical conundrums in antithrombotic therapy management: A Delphi Consensus panel
Keywords: CHA2DS2-دارواش; AF; atrial fibrillation; PE/VTE; pulmonary embolism and venous thromboembolism; EBM; Evidence Based Medicine; RCT; Randomized Controlled Trial; NOAC; Non-vitamin K antagonist oral anticoagulant; ACS/DES; acute coronary syndrome/drug eluting stent; CHA2DS2
Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation
Keywords: CHA2DS2-دارواش; Atrial fibrillation; ATRIA; CHA2DS2-VASc; Stroke; Thromboembolism;
Percutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial Fibrillation
Keywords: CHA2DS2-دارواش; atrial fibrillation; LAmbre; left atrial appendage closure; stroke; AF; atrial fibrillation; CHADS2; congestive heart failure, hypertension, age â¥75 years, diabetes mellitus, and prior stroke or transient ischemic attack; CHA2DS2-VASc; congestive he
CHA2DS2-VASc Score: A Predictor of Thromboembolic Events and Mortality in Patients With an Implantable Monitoring Device Without Atrial Fibrillation
Keywords: CHA2DS2-دارواش; ASSERT; Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial; CHA2DS2-VASc; congestive heart failure, hypertension, age 75 years, diabetes mellitus, stroke or transient isch
Strokes after cardioversion of atrial fibrillation - The FibStroke study
Keywords: CHA2DS2-دارواش; AF; atrial fibrillation; CHA2DS2-VASc; congestive heart failure, hypertension, age â¥Â 75 (doubled), diabetes mellitus, and prior Stroke, transient ischemic attack or thromboembolism (doubled), vascular disease, Age 65 to 74, sex category (female, unles
Initial experience with the WATCHMAN⢠left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry
Keywords: CHA2DS2-دارواش; Left atrial appendage closure; WATCHMANâ¢; Fibrillation auriculaire; Occlusion de l'auricule gauche; Prévention de l'accident vasculaire cérébral ischémique; Prothèse de WATCHMANâ¢; AF; atrial fibrillation; CHADS2; Cardiac failure, Hypertension
Association of Soluble CD40 Ligand With Duration of Atrial Fibrillation and With Intensity of Spontaneous Echocardiographic Contrast
Keywords: CHA2DS2-دارواش; atrial fibrillation; left atrial appendage thrombus; sCD40L levels; AUC; area under the curve; CD40L; CD40 ligand; CHA2DS2-VASc; congestive heart failure, hypertension, age â¥75years, diabetes mellitus, stroke/transient ischemic attack, vascular disease,
Original InvestigationAcute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin
Keywords: CHA2DS2-دارواش; acute kidney injury; atrial fibrillation; direct thrombin inhibitor; warfarin; AF; atrial fibrillation; AKI; acute kidney injury; ASMD; absolute standardized mean difference; CHA2DS2-VASc; congestive heart failure, hypertension, age 75 years or older, dia
Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation
Keywords: CHA2DS2-دارواش; AF; atrial fibrillation; CHA2DS2-VASc; congestive heart failure (1 point), hypertension (1 point), age 65-74 years (1 point) and age â¥75 years (2 points), diabetes mellitus (1 point), prior stroke or transient ischemic attack (2 points), vascular dise
CHA2DS2-VASc scores predict mortality after hospitalization for atrial fibrillation
Keywords: CHA2DS2-دارواش; Atrial fibrillation; CHA2DS2-VASc; Hospitalization; Mortality
Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke
Keywords: CHA2DS2-دارواش; Atrial fibrillation; Ischemic stroke; ECG; Predictors; CHADS2; CHA2DS2-VASc;
Patients with atrial fibrillation and CHA2DS2-VASc score 1: “To anticoagulate or not to anticoagulate? That is the question!”
Keywords: CHA2DS2-دارواش; ACC; American College of Cardiology; ACTIVE-W; Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events; AF; atrial fibrillation; AHA; American Heart Association; ARISTOTLE; Apixaban for Reduction in Stroke and Other Thrombo
The CHADS2 and CHA2DS2-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis
Keywords: CHA2DS2-دارواش; Atrial fibrillation; CHA2DS2-VASc; CHADS2; Asia;
Initiation of rivaroxaban in patients with nonvalvular atrial fibrillation at the primary care level:: The Swiss Therapy in Atrial Fibrillation for the Regulation of Coagulation (STAR) Study
Keywords: CHA2DS2-دارواش; AF; non-valvular atrial fibrillation; CHADS2; Congestive heart failure, Hypertension, Age â¥Â 75, Diabetes, Stroke [doubled]; CHA2DS2-VASc; Congestive heart failure/left ventricular dysfunction, Hypertension, Age 75 [doubled], Diabetes, Stroke [doubled]
Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of traffic accidents: A population-based cohort study
Keywords: CHA2DS2-دارواش; Atrial fibrillation; Traffic accident; Trauma; Antiplatelet; Anticoagulant; CHA2DS2-VASc
Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy
Keywords: CHA2DS2-دارواش; CHA2DS2-VASc; HAS-BLED; PCI; Stents;
Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of non-traffic-, non-cancer-related bone fractures: A population-based cohort study
Keywords: CHA2DS2-دارواش; Atrial fibrillation; Fracture; Osteoporosis; Antiplatelet; Anticoagulant; CHA2DS2-VASc;